Ultragenyx Pharmaceutical Inc. buy Piper Sandler
Start price
25.10.23
/
50%
€30.80
Target price
25.10.24
€122.98
Performance (%)
61.04%
End price
26.10.24
€49.60
Summary
This prediction ended on 26.10.24 with a price of €49.60. The BUY prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc. saw massive gains of 61.04%. Piper_Sandler has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.895% | -7.895% | -34.579% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Piper_Sandler for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target lowered by analysts at Piper Sandler from $135.00 to $130.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€41.20
13.01.25
13.01.25
€137.24
13.01.26
13.01.26
-32.04%
07:36
07:36
Stopped prediction by Piper_Sandler for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€35.20
17.03.25
17.03.25
€105.64
17.03.26
17.03.26
-20.45%
07:36
07:36